Annual Interest Expense
$26.61 M
+$12.51 M+88.69%
31 December 2023
Summary:
Xeris Biopharma Holdings annual interest expense is currently $26.61 million, with the most recent change of +$12.51 million (+88.69%) on 31 December 2023. During the last 3 years, it has risen by +$15.95 million (+149.62%). XERS annual interest expense is now at all-time high.XERS Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Interest Expense
$7.79 M
-$178.00 K-2.24%
30 September 2024
Summary:
Xeris Biopharma Holdings quarterly interest expense is currently $7.79 million, with the most recent change of -$178.00 thousand (-2.24%) on 30 September 2024. Over the past year, it has increased by +$939.00 thousand (+13.71%). XERS quarterly interest expense is now -2.24% below its all-time high of $7.96 million, reached on 30 June 2024.XERS Quarterly Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Interest Expense
$29.80 M
+$939.00 K+3.25%
30 September 2024
Summary:
Xeris Biopharma Holdings TTM interest expense is currently $29.80 million, with the most recent change of +$939.00 thousand (+3.25%) on 30 September 2024. Over the past year, it has increased by +$5.84 million (+24.38%). XERS TTM interest expense is now at all-time high.XERS TTM Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
XERS Interest Expense Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +88.7% | +13.7% | +24.4% |
| 3 y3 years | +149.6% | +333.0% | +198.8% |
| 5 y5 years | +945.5% | +122.0% | +345.6% |
XERS Interest Expense High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +270.6% | -2.2% | +333.5% | at high | +315.0% |
| 5 y | 5 years | at high | +945.5% | -2.2% | +419.4% | at high | +345.6% |
| alltime | all time | at high | >+9999.0% | -2.2% | at high |
Xeris Biopharma Holdings Interest Expense History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $7.79 M(-2.2%) | $29.80 M(+3.3%) |
| June 2024 | - | $7.96 M(+13.3%) | $28.86 M(+5.2%) |
| Mar 2024 | - | $7.03 M(+0.2%) | $27.43 M(+3.1%) |
| Dec 2023 | $26.61 M(+88.7%) | $7.02 M(+2.5%) | $26.61 M(+11.1%) |
| Sept 2023 | - | $6.85 M(+4.9%) | $23.96 M(+13.5%) |
| June 2023 | - | $6.53 M(+5.0%) | $21.10 M(+17.1%) |
| Mar 2023 | - | $6.22 M(+42.3%) | $18.02 M(+17.6%) |
| Dec 2022 | $14.10 M(+96.4%) | $4.37 M(+9.5%) | $15.32 M(+20.2%) |
| Sept 2022 | - | $3.99 M(+15.7%) | $12.75 M(+20.7%) |
| June 2022 | - | $3.45 M(-2.1%) | $10.56 M(+18.6%) |
| Mar 2022 | - | $3.52 M(+96.0%) | $8.91 M(+24.1%) |
| Dec 2021 | $7.18 M(-32.6%) | $1.80 M(-0.1%) | $7.18 M(-28.0%) |
| Sept 2021 | - | $1.80 M(+0.2%) | $9.97 M(-5.0%) |
| June 2021 | - | $1.79 M(+0.2%) | $10.51 M(-4.1%) |
| Mar 2021 | - | $1.79 M(-61.0%) | $10.95 M(+2.7%) |
| Dec 2020 | $10.66 M | $4.59 M(+97.2%) | $10.66 M(+40.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2020 | - | $2.33 M(+3.8%) | $7.60 M(-13.4%) |
| June 2020 | - | $2.24 M(+49.6%) | $8.78 M(+15.5%) |
| Mar 2020 | - | $1.50 M(-2.1%) | $7.60 M(+6.1%) |
| Dec 2019 | $7.16 M(+181.5%) | $1.53 M(-56.3%) | $7.16 M(+7.1%) |
| Sept 2019 | - | $3.51 M(+230.2%) | $6.69 M(+70.7%) |
| June 2019 | - | $1.06 M(-0.1%) | $3.92 M(+14.6%) |
| Mar 2019 | - | $1.06 M(+0.8%) | $3.42 M(+34.3%) |
| Dec 2018 | $2.54 M(>+9900.0%) | $1.05 M(+43.1%) | $2.54 M(+70.7%) |
| Sept 2018 | - | $737.00 K(+31.1%) | $1.49 M(+97.7%) |
| June 2018 | - | $562.00 K(+194.2%) | $754.00 K(+290.7%) |
| Mar 2018 | - | $191.00 K(>+9900.0%) | $193.00 K(+9550.0%) |
| Dec 2017 | $2000.00(0.0%) | $1000.00(>+9900.0%) | $2000.00(+100.0%) |
| Sept 2017 | - | $0.00(-100.0%) | $1000.00(0.0%) |
| June 2017 | - | $1000.00(>+9900.0%) | $1000.00(>+9900.0%) |
| Mar 2017 | - | $0.00 | $0.00 |
| Dec 2016 | $2000.00 | - | - |
FAQ
- What is Xeris Biopharma Holdings annual interest expense?
- What is the all time high annual interest expense for Xeris Biopharma Holdings?
- What is Xeris Biopharma Holdings annual interest expense year-on-year change?
- What is Xeris Biopharma Holdings quarterly interest expense?
- What is the all time high quarterly interest expense for Xeris Biopharma Holdings?
- What is Xeris Biopharma Holdings quarterly interest expense year-on-year change?
- What is Xeris Biopharma Holdings TTM interest expense?
- What is the all time high TTM interest expense for Xeris Biopharma Holdings?
- What is Xeris Biopharma Holdings TTM interest expense year-on-year change?
What is Xeris Biopharma Holdings annual interest expense?
The current annual interest expense of XERS is $26.61 M
What is the all time high annual interest expense for Xeris Biopharma Holdings?
Xeris Biopharma Holdings all-time high annual interest expense is $26.61 M
What is Xeris Biopharma Holdings annual interest expense year-on-year change?
Over the past year, XERS annual interest expense has changed by +$12.51 M (+88.69%)
What is Xeris Biopharma Holdings quarterly interest expense?
The current quarterly interest expense of XERS is $7.79 M
What is the all time high quarterly interest expense for Xeris Biopharma Holdings?
Xeris Biopharma Holdings all-time high quarterly interest expense is $7.96 M
What is Xeris Biopharma Holdings quarterly interest expense year-on-year change?
Over the past year, XERS quarterly interest expense has changed by +$939.00 K (+13.71%)
What is Xeris Biopharma Holdings TTM interest expense?
The current TTM interest expense of XERS is $29.80 M
What is the all time high TTM interest expense for Xeris Biopharma Holdings?
Xeris Biopharma Holdings all-time high TTM interest expense is $29.80 M
What is Xeris Biopharma Holdings TTM interest expense year-on-year change?
Over the past year, XERS TTM interest expense has changed by +$5.84 M (+24.38%)